Trials / Conditions / Coccidioidomycosis

Coccidioidomycosis

15 registered clinical trials studyying Coccidioidomycosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	To Find Effectiveness of Stretching Versus Soft Tissue Mobilization in Coccydynia in Postpartum Females NCT06913803	Superior University	N/A
Completed	A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica. NCT06523998	Caja Costarricense de Seguro Social	—
Withdrawn	SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole NCT04809649	George R Thompson	Phase 2
Completed	Safety and Pharmacokinetics of VT-1598 NCT04208321	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Person NCT03908632	National Institute of Allergy and Infectious Diseases (NIAID)	—
Terminated	Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment NCT03618992	University of Arizona	N/A
Completed	Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractor NCT03059992	Scynexis, Inc.	Phase 3
Withdrawn	Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis NCT02908334	University of California, San Francisco	Phase 2
Terminated	Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) NCT02663674	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 4
Recruiting	Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis NCT02190266	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthri NCT00796809	University of Arizona	—
Terminated	Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment NCT00614666	University of Arizona	Phase 1 / Phase 2
Completed	POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) NCT00423267	Merck Sharp & Dohme LLC	Phase 3
Completed	A Multi-center Study of Spherule-Derived Coccidioidin NCT00690092	Nielsen BioSciences, Inc.	Phase 3
Completed	A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where F NCT00002325	Pfizer	N/A